Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial

Marin H. Kollef, Martin Nováček, Ülo Kivistik, Álvaro Réa-Neto, Nobuaki Shime, Ignacio Martin-Loeches, Jean François Timsit, Richard G. Wunderink, Christopher J. Bruno, Jennifer A. Huntington, Gina Lin, Brian Yu, Joan R. Butterton, Elizabeth G. Rhee

Research output: Contribution to journalArticlepeer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial'. Together they form a unique fingerprint.

Medicine & Life Sciences